172 related articles for article (PubMed ID: 35522029)
1. Pharmacist-Led Deprescribing for Patients With Polypharmacy and Chronic Disease States: A Retrospective Cohort Study.
Chan M; Plakogiannis R; Stefanidis A; Chen M; Saraon T
J Pharm Pract; 2023 Oct; 36(5):1192-1200. PubMed ID: 35522029
[No Abstract] [Full Text] [Related]
2. Implementation of a compulsory clinical pharmacist-led medication deprescribing intervention in high-risk seniors in the emergency department.
Jovevski JJ; Smith CR; Roberts JL; Dev S; Iloabuchi TC; Gruber EA; Williams MJ; Slaven JE; Mitchell AM
Acad Emerg Med; 2023 Apr; 30(4):410-419. PubMed ID: 36794336
[TBL] [Abstract][Full Text] [Related]
3. Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis.
Gerardi S; Sperlea D; Levy SO; Bondurant-David K; Dang S; David PM; Lizotte A; Senécal L; Paquette F; Vanier MC
Am J Health Syst Pharm; 2022 Nov; 79(Suppl 4):S128-S135. PubMed ID: 35881917
[TBL] [Abstract][Full Text] [Related]
4. Impact of deprescribing rounds on discharge prescriptions: an interventional trial.
Edey R; Edwards N; Von Sychowski J; Bains A; Spence J; Martinusen D
Int J Clin Pharm; 2019 Feb; 41(1):159-166. PubMed ID: 30478496
[TBL] [Abstract][Full Text] [Related]
5. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
Balsom C; Pittman N; King R; Kelly D
Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991
[TBL] [Abstract][Full Text] [Related]
6. GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.
Anderson K; Freeman C; Foster M; Scott I
J Am Geriatr Soc; 2020 Feb; 68(2):403-410. PubMed ID: 31792947
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Pharmacist-Managed Nonsteroidal Anti-Inflammatory Drugs Deprescribing Program in an Integrated Health Care System.
Rashid R; Chang C; Niu F; Deguzman L; Draves M; Awsare S; Hui R
J Manag Care Spec Pharm; 2020 Jul; 26(7):918-924. PubMed ID: 32584681
[TBL] [Abstract][Full Text] [Related]
8. Pharmacist-led medication review in a residential in-reach service leads to deprescribing.
Hui JH; Parikh S; Kouladjian O'Donnell L; Mcinerney B; Dillon L; Poojary S; Crabtree A
Australas J Ageing; 2023 Dec; 42(4):675-682. PubMed ID: 37198738
[TBL] [Abstract][Full Text] [Related]
9. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
[TBL] [Abstract][Full Text] [Related]
10. Pharmacist-driven deprescribing initiative in primary care.
Rea E; Portman D; Ioannou K; Lumley B
J Am Pharm Assoc (2003); 2024; 64(1):139-145. PubMed ID: 37722503
[TBL] [Abstract][Full Text] [Related]
11. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
McIntyre C; McQuillan R; Bell C; Battistella M
Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
[TBL] [Abstract][Full Text] [Related]
12. Community-based pharmacists' role in deprescribing: A systematic review.
Bužančić I; Kummer I; Držaić M; Ortner Hadžiabdić M
Br J Clin Pharmacol; 2022 Feb; 88(2):452-463. PubMed ID: 34155673
[TBL] [Abstract][Full Text] [Related]
13. Can a practice pharmacist improve prescribing safety and reduce costs in polypharmacy patients? A pilot study of an intervention in an Irish general practice setting.
Ó Ciardha D; Blake AM; Creane D; Callaghan MÓ; Darker C
BMJ Open; 2022 May; 12(5):e050261. PubMed ID: 35623753
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
Komagamine J; Sugawara K; Hagane K
BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
[TBL] [Abstract][Full Text] [Related]
15. Deprescribing Medications for Chronic Diseases Management in Primary Care Settings: A Systematic Review of Randomized Controlled Trials.
Dills H; Shah K; Messinger-Rapport B; Bradford K; Syed Q
J Am Med Dir Assoc; 2018 Nov; 19(11):923-935.e2. PubMed ID: 30108032
[TBL] [Abstract][Full Text] [Related]
16. Implementation of a Pharmacist-Driven Aspirin Deprescribing Protocol Among Older Veterans in a Primary Care Setting.
Varghese CJ; Grunske M; Nagy MW
Sr Care Pharm; 2024 Jun; 39(6):228-234. PubMed ID: 38803026
[No Abstract] [Full Text] [Related]
17. Deprescribing potentially inappropriate medications in memory clinic patients (DePIMM): A feasibility study.
Cross AJ; George J; Woodward MC; Le VJ; Elliott RA
Res Social Adm Pharm; 2020 Oct; 16(10):1392-1397. PubMed ID: 32014358
[TBL] [Abstract][Full Text] [Related]
18. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary Team Deprescribing Intervention for Polypharmacy in Elderly Orthopedic Inpatients: A Propensity Score-matched Analysis of a Retrospective Cohort Study.
Seto H; Ishimaru N; Ohnishi J; Kanzawa Y; Nakajima T; Shimokawa T; Imanaka Y; Kinami S
Intern Med; 2022 Aug; 61(16):2417-2426. PubMed ID: 35022357
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of pharmacist-led physician-supported inpatient deprescribing model in older patients admitted to an acute general medical unit.
Potter EL; Lew TE; Sooriyakumaran M; Edwards AM; Tong E; Aung AK
Australas J Ageing; 2019 Sep; 38(3):206-210. PubMed ID: 30868694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
